Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Shandong Sinobioway Biomedicine

Market Cap: CN¥5.3b

Shandong Sinobioway Biomedicine Co., Ltd.

Standard Chemical & Pharmaceutical

Market Cap: NT$10.1b

Standard Chemical & Pharmaceutical Co. Ltd.

Novartis India

Market Cap: ₹21.6b

Novartis India Limited is involved in the pharmaceutical business in India.

Emcure Pharmaceuticals

Market Cap: ₹243.4b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Anuh Pharma

Market Cap: ₹8.3b

Engages in the manufacture and sale of bulk drugs and chemicals in India.

PharmaEssentia

Market Cap: NT$189.4b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

FunPep

Market Cap: JP¥4.3b

Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.

Morepen Laboratories

Market Cap: ₹26.8b

Develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.

Vectorite Biomedical

Market Cap: NT$551.5m

Engages in the research and development of biotechnology in Taiwan and internationally.

Shinpoong PharmaceuticalLtd

Market Cap: ₩696.5b

Manufactures and sells pharmaceutical products in South Korea.

Shanghai OPM Biosciences

Market Cap: CN¥7.5b

Provides cell culture media and CDMO services in China and internationally.

Kingchem (Liaoning) Life Science

Market Cap: CN¥4.3b

Kingchem (Liaoning) Life Science Co., Ltd.

Alpa Laboratories

Market Cap: ₹1.9b

Engages in the manufacture and sale of drugs and chemicals in India.

Veritas In Silico

Market Cap: JP¥4.7b

Engages in the business of small molecule drug discovery and nucleic acid drug discovery targeting mRNA.

Maccura BiotechnologyLtd

Market Cap: CN¥7.0b

Engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally.

Xinjiang Bai Hua Cun Pharma TechLtd

Market Cap: CN¥3.4b

Engages in the pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.

Medy-Tox

Market Cap: ₩846.5b

Operates as a biopharmaceutical company in South Korea.

ALTEOGEN

Market Cap: ₩23.9t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Senhwa Biosciences

Market Cap: NT$3.7b

A drug development company, engages in the development of new drugs and targeted agents.

Blue Jet Healthcare

Market Cap: ₹112.0b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

Modern Chinese Medicine Group

Market Cap: HK$511.2m

An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.

SMO ClinPlusLTD

Market Cap: CN¥3.6b

Provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China.

BRIM Biotechnology

Market Cap: NT$4.2b

A clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases.

Shandong Xinhua Pharmaceutical

Market Cap: HK$9.9b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

Santen Pharmaceutical

Market Cap: JP¥534.7b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Divi's Laboratories

Market Cap: ₹1.5t

Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

TransThera Sciences (Nanjing)

Market Cap: HK$56.8b

TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases.

TaiRx

Market Cap: NT$3.0b

Focuses on the development and commercialization of therapeutics for the treatment of cancer and other diseases.

PKU HealthCareLtd

Market Cap: CN¥3.6b

Researches, develops, manufactures, and sells pharmaceutical products in China.

Nyrada

Market Cap: AU$68.1m

A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.

IOL Chemicals and Pharmaceuticals

Market Cap: ₹30.5b

Manufactures and sells pharmaceutical and chemical products in India and internationally.

Shanghai New World

Market Cap: CN¥4.8b

Owns and operates department stores in China.

Nippon Shinyaku

Market Cap: JP¥226.9b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Yabao Pharmaceutical Group

Market Cap: CN¥4.6b

Researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally.

Pharmosa Biopharm

Market Cap: NT$5.9b

A biotechnology company, focuses on developing drugs in Taiwan.

Shukra Pharmaceuticals

Market Cap: ₹15.1b

Manufactures and markets pharmaceutical products in India and internationally.